{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:42:54Z","timestamp":1792500174405,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.radonc.2021.04.008","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T17:34:52Z","timestamp":1618680892000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses"],"prefix":"10.1016","volume":"160","author":[{"given":"Almut","family":"Dutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9450-6859","authenticated-orcid":false,"given":"Armin","family":"L\u00fchr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther G.C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Agolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"B\u00fctof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2531-6920","authenticated-orcid":false,"given":"Xavier","family":"Vermeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Geismar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7017-3738","authenticated-orcid":false,"given":"Steffen","family":"L\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2021.04.008_b0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2021.04.008_b0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00066-016-1005-9","article-title":"Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma","volume":"192","author":"Harrabi","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2021.04.008_b0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.14338\/IJPT-14-00026.1","article-title":"Comparative proton and photon treatment planning in pediatric patients with various diagnoses","volume":"2","author":"Kristensen","year":"2015","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2021.04.008_b0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/02841860701218626","article-title":"A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; Implications for the long-term morbidity of cancer survivors","volume":"46","author":"Palm","year":"2007","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx208","article-title":"Quality of life and patient-reported outcomes following proton radiation therapy: A systematic review","volume":"110","author":"Verma","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2021.04.008_b0030","unstructured":"Particle Therapy Co-Operative Group. Particle therapy facilities in operation. [cited 2020 May 07], 2020. URL: https:\/\/www.ptcog.ch\/index.php\/facilities-in-operation."},{"key":"10.1016\/j.radonc.2021.04.008_b0035","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/1878-0261.12731","article-title":"What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond","volume":"14","author":"Baumann","year":"2020","journal-title":"Mol Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejca.2016.04.008","article-title":"Individual patient information to select patients for different radiation techniques","volume":"62","author":"Quik","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2021.04.008_b0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2015.10.004","article-title":"The quest for evidence for proton therapy: Model-based approach and precision medicine","volume":"95","author":"Widder","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0060","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1118\/1.4762562","article-title":"Brain necrosis after fractionated radiation therapy: Is the halftime for repair longer than we thought?","volume":"39","author":"Bender","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2019.09.008","article-title":"Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model","volume":"142","author":"Niyazi","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0070","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","article-title":"Radiation dose-volume effects in the brain","volume":"76","author":"Lawrence","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0075","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1016\/j.ijrobp.2011.10.021","article-title":"Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors","volume":"83","author":"Gondi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0360-3016(00)00493-4","article-title":"Calculation of cranial nerve complication probability for acoustic neuroma radiosurgery","volume":"47","author":"Meeks","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0085","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0360-3016(00)01387-0","article-title":"Hypothalamic\/pituitary function following high-dose conformal radiotherapy to the base of skull: Demonstration of a dose-effect relationship using dose-volume histogram analysis","volume":"49","author":"Pai","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0090","doi-asserted-by":"crossref","first-page":"20140413","DOI":"10.1259\/bjr.20140413","article-title":"Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy","volume":"88","author":"De Marzi","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2021.04.008_b0095","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13014-015-0501-x","article-title":"Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy","volume":"10","author":"Lee","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0100","doi-asserted-by":"crossref","first-page":"20130459","DOI":"10.1259\/bjr.20130459","article-title":"Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours","volume":"86","author":"Batth","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2021.04.008_b0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0360-3016(97)00029-1","article-title":"Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors","volume":"38","author":"Martel","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0110","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2019.11.013","article-title":"Modelling the risk of radiation induced alopecia in brain tumor patients treated with scanned proton beams","volume":"144","author":"Palma","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2018.06.036","article-title":"Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours","volume":"130","author":"Dutz","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0125","unstructured":"DRKS00007670. Proton therapy of brain tumors: Prospective collection of effectiveness and side effects with standard clinical doses (Proto-R-Hirn). German Clinical Trials Center [Internet], Cologne: German Institute of Medical Documentation and Information (Germany), 2008. Identifier DRKS00007670 [registered 2015 Feb 02, cited 2020 May 07], 2015. URL: https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00007670."},{"key":"10.1016\/j.radonc.2021.04.008_b0130","unstructured":"DRKS00008569. Proton therapy of skull base tumors: Prospective collection of effectiveness and side effects with standard clinical doses (Proto-R-Sch\u00e4delbasis). German Clinical Trials Center [Internet], Cologne: German Institute of Medical Documentation and Information (Germany), 2008. Identifier DRKS00008569 [registered 2015 May 21, cited 2020 May 07], 2015. URL: https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00008569."},{"key":"10.1016\/j.radonc.2021.04.008_b0135","unstructured":"NCT02824731. Comparison of proton and photon radiotherapy of brain tumors (ProtoChoice-Hirn). ClinicalTrials.gov [Internet], Bethesda (MD): National Library of Medicine (US), 2000 Feb 29. Identifier NCT02824731 [registered 2016 July 07, updated 2019 Feb 18, cited 2020 May 07], 2016. URL: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02824731."},{"key":"10.1016\/j.radonc.2021.04.008_b0140","unstructured":"DRKS00004384. Register study standard proton therapy WPE- Adults - (ProReg). German Clinical Trials Center [Internet], Cologne: German Institute of Medical Documentation and Information (Germany), 2008. Identifier: DRKS00004384 [registered 2012 Sep 28, cited 2020 May 07], 2012. URL: https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00004384."},{"key":"10.1016\/j.radonc.2021.04.008_b0145","doi-asserted-by":"crossref","unstructured":"Schmahmann JD, Doyon J, McDonald D, etal. Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space. Neuroimage 1999;10:233\u2013260.","DOI":"10.1006\/nimg.1999.0459"},{"key":"10.1016\/j.radonc.2021.04.008_b0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/COC.0b013e318178e4e8","article-title":"A radiation oncologists guide to contouring the hippocampus","volume":"32","author":"Chera","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0155","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.radonc.2013.10.035","article-title":"Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0160","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2015.01.016","article-title":"Organs at risk in the brain and their dose-constraints in adults and in children: A radiation oncologist\u2019s guide for delineation in everyday practice","volume":"114","author":"Scoccianti","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2017.12.013","article-title":"The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology","volume":"128","author":"Eekers","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0170","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0360-3016(96)00601-3","article-title":"A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: Application to the prostate","volume":"37","author":"Van't Riet","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0175","doi-asserted-by":"crossref","unstructured":"ICRU. ICRU Report 83 - Prescribing, recording, and reporting photon-beam intensity modulated radiation therapy (IMRT). J ICRU 10:1-106, 2010.","DOI":"10.1093\/jicru\/10.1.Report83"},{"key":"10.1016\/j.radonc.2021.04.008_b0180","doi-asserted-by":"crossref","first-page":"26378","DOI":"10.1038\/srep26378","article-title":"LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma","volume":"6","author":"Kong","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2021.04.008_b0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semradonc.2017.11.008","article-title":"Clinical trial strategies to compare protons with photons","volume":"28","author":"Langendijk","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7785\/tcrt.2012.500276","article-title":"A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy","volume":"12","author":"Dennis","year":"2013","journal-title":"Technol Cancer Res T"},{"key":"10.1016\/j.radonc.2021.04.008_b0195","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s00066-016-1007-7","article-title":"Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma","volume":"192","author":"Adeberg","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2021.04.008_b0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/0284186X.2018.1529424","article-title":"Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: Results of a multicentric in silico ROCOCO trial","volume":"58","author":"Eekers","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0205","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0360-3016(00)01422-X","article-title":"A comparison of dose distributions of proton and photon beams in stereotactic conformal radiotherapy of brain lesions","volume":"49","author":"Baumert","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(03)00117-8","article-title":"Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: A treatment planning study","volume":"68","author":"Bolsi","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0215","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/cancers10110401","article-title":"Dosimetric comparison of proton radiation therapy, volumetric modulated arc therapy, and three-dimensional conformal radiotherapy based on intracranial tumor location","volume":"10","author":"Adeberg","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2021.04.008_b0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.radonc.2020.07.056","article-title":"First experience with model-based selection of head and neck cancer patients for proton therapy","volume":"151","author":"Tambas","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0225","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3389\/fonc.2019.00991","article-title":"Evaluation of the hippocampal normal tissue complication model in a prospective cohort of low grade glioma patients-an analysis within the EORTC 22033 clinical trial","volume":"9","author":"Jaspers","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0230","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00066-006-1500-5","article-title":"Comparative planning study for proton radiotherapy of benign brain tumors","volume":"182","author":"Cozzi","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2021.04.008_b0235","doi-asserted-by":"crossref","first-page":"E384","DOI":"10.1016\/j.ijrobp.2019.06.1648","article-title":"Comprehensive NTCP-profiling to predict radiation-induced side effects in head and neck cancer patients treated with definitive radiotherapy","volume":"105","author":"Van den Bosch","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0240","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2021.04.008_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD Statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.radonc.2021.04.008_b0250","doi-asserted-by":"crossref","unstructured":"Dutz A, L\u00fchr A, Agolli L, et al. Modelling of late side-effects following cranial proton beam therapy. Radiother Oncol 2021;157. [Epub ahead of print] DOI: 10.1016\/j.radonc.2021.01.004.","DOI":"10.1016\/j.radonc.2021.01.004"},{"key":"10.1016\/j.radonc.2021.04.008_b0255","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.radonc.2019.12.024","article-title":"Neurocognitive function and quality of life after proton beam therapy for brain tumour patients","volume":"143","author":"Dutz","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0260","doi-asserted-by":"crossref","first-page":"R419","DOI":"10.1088\/0031-9155\/59\/22\/R419","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer","volume":"59","author":"Paganetti","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2021.04.008_b0265","first-page":"35","article-title":"Relative biological effectiveness in proton beam therapy \u2013 Current knowledge and future challenges","volume":"9","author":"L\u00fchr","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0270","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2018.05.018","article-title":"\u201cRadiobiology of Proton Therapy\u201d: Results of an international expert workshop","volume":"128","author":"L\u00fchr","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0275","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1080\/0284186X.2019.1631477","article-title":"Predicting late magnetic resonance image changes in glioma patients after proton therapy","volume":"58","author":"Eulitz","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0280","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2020.03.013","article-title":"Late contrast enhancing brain lesions in proton-treated patients with low-grade glioma: Clinical evidence for increased periventricular sensitivity and variable RBE","volume":"107","author":"Bahn","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.04.008_b0285","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2018.05.001","article-title":"Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus","volume":"128","author":"Lambrecht","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0290","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2019.08.005","article-title":"Practical robustness evaluation in radiotherapy - A photon and proton-proof alternative to PTV-based plan evaluation","volume":"141","author":"Korevaar","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0295","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.radonc.2017.09.028","article-title":"The impact of treatment accuracy on proton therapy patient selection for oropharyngeal cancer patients","volume":"125","author":"Arts","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0300","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1080\/0284186X.2017.1355113","article-title":"Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy","volume":"56","author":"Bijman","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0305","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2011.08.009","article-title":"Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study","volume":"105","author":"Christianen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.04.008_b0310","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.radonc.2014.10.001","article-title":"Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets","volume":"113","author":"Skripcak","year":"2014","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021061909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021061909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:15:05Z","timestamp":1759122905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814021061909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":62,"alternative-id":["S0167814021061909"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.04.008","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}